In This Section

Contact
E-mail
RAI.US [at] cslbehring.com
Location - People View

3615 Civic Center Blvd
Philadelphia, PA 19104
United States

Related Topics

Science Center Research Acceleration Initiative

Published on
Feb 5, 2020
AddtoAny
Share:

CSL-Science Center Research Acceleration Initiative is awarding three proposals of $200,000 per year for up to two years (max $400,000 funding).

Behring is a leading global biotechnology company that develops and delivers innovative biotherapies to help people living with life threatening medical conditions live full lives. CSL has partnered with the University City Science Center, a nonprofit institution dedicated to identifying and nurturing promising technology for over 50 years, to build the CSL-Science Center Research Acceleration Initiative. The initiative is designed to source research and fast-track discovery through partnerships between CSL and regional research institutions. Selected projects receive funding and access to industry resources for scientists working on novel technologies in CSL’s therapeutic areas.

FUNDING MECHANISM

The Initiative will fund up to three proposals in 2020. Successful applicants will receive up to $200,000 per year for up to two years (maximum $400,000 funding) to accelerate translation of their research. Because the awards will be in the form of research partnerships, interested investigators must engage their institution’s technology transfer office prior to submitting an application. Applications will be accepted through April 13, 2020.

The CSL – Science Center Research Acceleration Initiative seeks innovations that address CSL Therapeutic and Focus areas, and that are amenable to or include a listed Modality below:

THERAPEUTIC AREAS (emphasis on rare disease)

  • Immunology
  • Neurology
  • Hematology
  • Thrombosis
  • Transplant
  • Respiratory Cardiovascular / Metabolic

FOCUS AREAS

  • Novel drug targets
  • Novel therapeutic candidates
  • Novel strategies for treating disease

MODALITIES

  • Antibodies
  • Protein therapeutics
  • Gene therapies
  • Cell therapies
  • Small molecules not of interest

TIMELINE AND INFORMATION

March 2, 2020: Opening day for pre-proposal applications

April 13, 2020: Deadline for receipt of pre-proposal applications

June 25, 2020: Finalist applicants present research proposals at SC to CSL

July 30, 2020: Finalist applicants selected for funding

PROPOSAL SUMBISSION

To submit proposals or for more information, please visit our website: https://sciencecenter.org/discover/csl.

For questions regarding the initiative and details of partnering with CSL, email RAI.US@cslbehring.com.